Keyphrases
All Life Cycle
16%
Biosynthetic Pathway
16%
Cell Surface
33%
Chagas Disease
50%
Chemical Space
33%
Competitive Inhibitor
16%
Compound 3
16%
Compound II
16%
Conventional Drugs
16%
Deconvolution
16%
Dolichol
16%
Drug Discovery
33%
Drug-like
16%
Enzyme Forms
16%
GDP-mannose
16%
GDP-mannose Pyrophosphorylase
83%
Global Health Issue
16%
Glycoconjugates
33%
GPI-anchored Protein (GPI-AP)
16%
Guanosine Diphosphate
100%
Life Cycle Stages
16%
Ligandability
100%
Mannose
100%
Mucin Glycoprotein
16%
New Therapeutic Agents
16%
Nucleotide Sugars
33%
Phospholipids
16%
Phosphomannomutase
100%
Pyrophosphatase
100%
Retesting
16%
Small Fragments
16%
Small Molecules
16%
Surface Architecture
16%
Therapeutic Target
16%
Trypanosoma Cruzi (T. cruzi)
100%
Uncompetitive Inhibitor
16%
Biochemistry, Genetics and Molecular Biology
Anabolism
12%
Competitive Inhibition
12%
Dolichol
12%
Enzyme
75%
Glycoconjugate
25%
Glycoprotein
12%
Glycosylphosphatidylinositol
12%
Guanosine Diphosphate Mannose
100%
Life Cycle Stage
12%
Mannose
100%
Mucin
12%
Nucleotide Sugar
25%
Phospholipid
12%
Phosphomannomutase
100%
Small Molecule
12%
Trypanosoma Cruzi
100%
Uncompetitive Inhibitor
12%
Pharmacology, Toxicology and Pharmaceutical Science
Chagas Disease
37%
Competitive Inhibitor
12%
Disease
12%
Dolichol
12%
Drug Discovery
25%
Glycoconjugate
25%
Glycoprotein
12%
Glycosylphosphatidylinositol
12%
Guanosine Diphosphate Mannose
100%
Life Cycle Stage
12%
Mannose
100%
Mannose Phosphate
12%
Mucin
12%
Phospholipid
12%
Phosphomannomutase
100%
Sugar Nucleotide
25%
Trypanosoma Cruzi
100%
Immunology and Microbiology
Biosynthesis
33%
Cell Surface
66%
Chagas Disease
100%
Competitive Inhibition
33%
Glycoconjugate
66%
Glycoprotein
33%
Life Cycle Stage
33%
Mucin
33%
Trypanosoma Cruzi
100%